June 22 – 23, 2021 (EDT) | Virtual Conference The American Conference Institute invites you to attend the Virtual 12th Summit on Biosimilars & Innovator Biologics on June 22-23, 2021! Gain government and industry insights on the Innovator and Biosimilars Marketplace from the U.S. FTC, U.S. FDA,… Read More »12th Summit on Biosimilars & Innovator Biologics
The 3rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drug delivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative diseases. Now in its third year, this digital forum is the industry’s definitive blood-brain barrier conference, focused exclusively on… Read More »3rd Annual Blood-Brain Barrier Summit
Our expert panel weighs in on health systems addressing behavioral issues and supporting the mental health of doctors, nurses and others.
Learn from our expert panel as they discuss the challenges and opportunities of value-based contracting.
Learn from payers focused on health tech, medical device investors and others on what investment trends to watch for this year.
Covid-19 has renewed interest in diagnostics and a way to deliver care at home. Learn from companies and experts as they address the future of these two developments.
Learn how health systems and health plans are addressing care gaps with minorities and what strategies are being utilized to close those gaps.
The finalists across health IT, biopharma, medical devices, diagnostics, and health services tracks were judged on criteria that included: completeness of overall plan, business idea, market opportunity, revenue model, and founder(s) experience.
The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. This is a strategic conference designed to bring drug development teams together to address critical challenges surrounding therapeutic potency, tumor resistance and relapse and expanding the… Read More »Non-Small Cell Lung Cancer Drug Development Summit
Returning digitally in 2021, the 2nd Annual Gene Therapy for Neurological Disorders Europe meeting will possibly be your last chance to attend a European meeting without the airmiles! Focusing on the industry’s challenges of developing and delivering gene therapies to the CNS and bringing fresh faces and emerging… Read More »2nd Gene Therapy for Neurological Disorders Europe
AI, therapeutics for autoimmune diseases, automation for biomedical research and oncology are among the areas of interest for the finalists in the biopharma track scheduled for day two of the conference.
On Wednesday, April 28th, the World Orphan Drug Congress USA is being held online for free! The conference brings together pharma, biotechs, government, payers, investors and patient/patient advocates in the rare disease space to discuss the latest developments that will lead to the future of… Read More »World Orphan Drug Congress USA Virtual 2021
The 2nd Gene Therapy Immunogenicity Summit is the industry’s definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate. In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and… Read More »2nd Gene Therapy Immunogenicity
Surgical retractor systems, catheters, minimally invasive surgery, wireless power transfer technology, microwave ablation, and jaundice treatment are among the areas the six medical device finalists cover.
This is the definitive drug development forum for research teams to investigate how to modulate the cGAS-STING and Toll-like receptor (7/8/9) pathways both as monotherapies and as adjuvants in combinatorial approaches. This meeting comes at a critical point for the cancer immunotherapy field, as researchers look to increase… Read More »STING & TLR Targeting Therapies Summit
Representatives from five health services startups will present their companies to three judges, followed by a Q&A. The judges for the health services track include: Cheryl Chang of BlueRun Ventures; Keith Figlioli of LRVHealth, and Steve Tolle of HLM Venture Partners.
The conference highlights the intersections of technology and life sciences through the prism of precision medicine. The topics at the conference span pediatric innovation in precision medicine, how tech companies are addressing clinical trial challenges, supply chain management, and more.
Finalists for the diagnostics track at INVEST Pitch Perfect include tests for upper respiratory infections, breast cancer screening, in vitro cellular immunoassays, dysphagia diagnostics, and neuroscience.
With high stakes to satisfy unmet patient needs, cell therapy is a promising but challenging field of oncology. There is a crucial need to progress candidates from bench to bedside. With that in mind, I am delighted to share the official agenda and speaker faculty… Read More »9th PREDiCT: Tumor Models Cell Therapy Summit
With that in mind, the 3rd Cell Engager Summit (June 30 – July 1) is the only industry-led meeting focused on developing multi-specific cell engaging therapies in solid tumor indications, and accelerating early discovery innovation into the clinic. With over 32 world-class speakers set to share their ground-breaking insights, this… Read More »3rd Cell Engager Summit
Companies focusing on cancer care, high-risk patients, patient safety, tele-dermatology, mental health and medical billing are among the six finalists.
Florida Health Care Association hosts the premier conference for long-term care professionals in the state. As our attendees continue to serve on the frontline of the COVID-19 pandemic, our priority remains on keeping everyone safe while still providing vital information and education on emerging long-term… Read More »FHCA (Florida Health Care Association)
Healthcare delivery is one of the themes at the annual MedCity News virtual INVEST conference, April 19-23. Register today!
In the fight against emerging coronavirus variants and spike mutations, the need for long-lasting immunity is greater than ever. This is why the time is now to look beyond antibodies and capitalize on the long-term immune response of T cell therapies. The Cell-Mediated Therapies for Infectious Disease… Read More »Cell-Mediated Therapies for Infectious Disease Summit
Built with thought leaders from Seattle Genetics, Precision Biosciences and Kite Pharma, the inaugural industry-focused BCMA Targeted Therapies Summit will share the field’s cutting-edge and aggressive scientific advances of BCMA therapies within multiple myeloma. This summit is the first of its kind, uniting thought leaders… Read More »BCMA Targeted Therapies Summit
Join the Epigenetic Therapeutic Targets Summit – the only virtual summit dedicated to the clinical translation and optimization of therapeutic candidates targeting epigenetic mechanisms of gene expression. Hear the latest clinical advancements in therapeutic interventions targeting all areas of epigenetic machinery, including DNA methylation, histone… Read More »Epigenetic Therapeutic Targets Summit
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients During the… Read More »Insights+ Key Biosimilars Events of February 2021
The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only… Read More »Genetic Vaccine Development for Infectious Diseases Summit
Drug Delivery Devices Symposium 10 March 2021 | GMT (UTC+0) We have the distinct privilege of unveiling Oxford Global’s Drug Delivery Devices Symposium, taking place on the 10th of March, 2021. Free Passes Now Available: https://bit.ly/2YoWrId This one-of-a-kind event brings together global leaders in the Drug… Read More »Drug Delivery Devices Symposium
Close the Clinical Gap, Discover the Next Generation of Microbiome-based Therapeutics, and Establish New Partnerships to Accelerate Your Research The most comprehensive forum for microbiome drug developers, the Microbiome Movement – Drug Development Summit returns for its sixth iteration! We will continue to unite forward-thinking researchers from the… Read More »6th Microbiome Movement – Drug Development Summit
How are health systems and payers addressing gaps in care for minorities? Learn how at MedCity INVEST
MedCity News has assembled compelling speakers to address the Covid-prompted rapid transformation of healthcare at this year’s virtual INVEST conference, April 19-23.
The 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications. Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and… Read More »2nd TCR-based Therapies Summit
Advance Cutting-Edge Research and Development with Next-Generation Cell Therapies, to Deliver Best-in-Class Products to Patients in Need Cell therapies hold life-saving potential for patients, and the race is on to develop a best-in-class, living, ‘thinking’ drugs. Relapse rates and barriers to solid tumor efficacy mean… Read More »Multi-Functional Cell Therapies Summit
The MedCity INVEST conference, April 19-23, will include a new session called Ask the Investor. The goal is to provide a forum for healthcare startups to better understand investment strategies for different groups and to ask investors questions.
INVEST will address six broad themes through a mix of live and pre-recorded sessions: Public Health and Health Equity; Healthcare Delivery; Healthcare Investing & Financing; Empowering Patients; Behavioral Health; and Employer Health.
Improving the Safety, Efficacy & Predictability of Monotherapy & Combinatorial Therapies to Fast-track the Discovery & Development of TNBC Treatments to Reach Patients in Need This is the primary industry platform specifically dedicated to providing you insight into the latest developments of safe and efficacious… Read More »Triple Negative Breast Cancer Drug Development Digital Summit
Harness the Maternal-Infant Microbiome, Establish New Mechanisms of Action, and Develop Breakthrough Health Products that Proactively Prevent Disease Risk Returning for another year, the 3rd Microbiome Movement – Maternal & Infant Health Summit will unite industry and academics in the exploration of preventative and therapeutic… Read More »3rd Microbiome Movement – Maternal & Infant Health Summit
The MedCity INVEST conference, April 19-23, will include a new session called Ask the Investor. The goal is to provide a forum for healthcare startups to better understand investment strategies for different groups and to ask investors questions.
The upcoming MedCity INVEST conference will include a new session, Ask the Investor. The goal is to provide a forum for healthcare startups to better understand investment strategies for different groups and to ask investors questions.
The startup pitch contest is part of our INVEST conference, April 19-23, which will be hosted online due to the Covid-19 public health crisis. It includes five tracks for startups: biopharma, medical devices, diagnostics, health IT and health services.
The INVEST Pitch Perfect contest is part of our INVEST conference April 19-23, which will be hosted online due to Covid-19, and includes five tracks for startups: biopharma, medical devices, diagnostics, health IT and health services. Read more on how to apply.
Rebuild clinical trials in the image of patient need. Join Sanofi, Janssen, FDA, Pfizer and more [Sponsored]
Clinical 2021 is US and EU pharma’s leading event for clinical innovators – join 500+ executive attendees from across the globe to meet and learn virtually.
The inaugural Gene Therapy Comparability Summit is the only industry dedicated meeting to ensuring your manufacturing processes are effective and comparable at every stage of development, supporting a seamless transition to the larger scales required for commercialization. This meeting will unite large pharma and innovative biotechs including Pfizer,… Read More »Gene Therapy Comparability
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers… Read More »Gene Therapy for Muscular Disorders
Making new connections is vital to helping the biotech industry continue their journey. Bio Integrates creates these opportunities and provides attendees with significant opportunities to learn from and interact with our growing community, to enhance both current and future needs. Our debate-led format provides our… Read More »Bio Integrates 2021 (Digital)
Insights+ Exclusive: Key Takeaways from the Webinar on HEOR/ HTA: The Evolving Role in the Indian Healthcare Ecosystem
Intellimed Healthcare Solutions organized an online webinar on “Health Economics and Outcomes Research/ Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem” on 15th January 2021. The objective was to gain insights into the current scenario and the need for HEOR/HTA in India.… Read More »Insights+ Exclusive: Key Takeaways from the Webinar on HEOR/ HTA: The Evolving Role in the Indian Healthcare Ecosystem
In addition to panel discussions, MedCity News is hosting intimate sessions that will allow startups to understand the investment strategies of leading healthcare investors and give them the opportunity to engage in a Q&A with them
Pharma companies moved fast in 2020 to tackle Covid-19 and to address longstanding issues of racial equity, the CEOS of BD and Sanofi said in a session at the J.P. Morgan Healthcare Conference. The challenge lies in keeping the momentum going in 2021.
Twenty-twenty has demonstrated the need for a 24/7, reliable manufacturing environment. Emulating on the first edition in 2020, the 2nd Manufacturing Assets & Facility Management in Pharma (MAFM) Summit will return in May, dedicated to aiding Engineering, Maintenance & Manufacturing Facilities leaders to collaborate. This exclusive, industry-led community will enable you to reduce COGs and maximize efficiency over just 3 days! Join this cutting-edge discussion with… Read More »2nd Manufacturing Assets & Facility Management in Pharma (MAFM) Summit
Network with over 50 other industry pioneers including Ionis Pharmaceuticals, Genentech, Vicore, and AnaMar to hear first-hand how the latest scientific research is innovating and upgrading ILD therapeutics at this trailblazing new meeting. The 1st Interstitial Lung Disease Drug Development Summit is a ground-breaking new conference dedicated to helping… Read More »Interstitial Lung Disease (ILD) Drug Development Summit
Exclusive Webinar: Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem
Intellimed in collaboration with alpha MD & IMPA along with PharmaShots as the media partner is gladly organizing a webinar on “Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem” The objective of the webinar is to discuss… Read More »Exclusive Webinar: Health Economics & Outcomes Research /Health Technology Assessment: The evolving role in the Indian Healthcare Ecosystem
Medtronic CEO expects to submit renal denervation data to FDA this year, overcoming previous failures
Medtronic suffered a shocking setback back in 2014 when its Symplicity 3 pivotal trial failed to meet its primary endpoint of reducing blood pressure meaningfully. Now it is gearing up to present new data to the FDA.
The Lincoln Health Network is excited to announce our 2nd Medical Writing Landscape Advancement Summit, March 3-4, 2021. Join us virtually, on the LHN virtual event platform to improve your medical writing strategies by understanding evolving regulatory protocols and submission guidelines, and learn how to… Read More »Medical Writing Landscape Advancement Summit | Virtual
The panel, What It Takes To Build A Successful, Regional BioInnovation Hub (sponsored by Independence Blue Cross) focuses on Philadelphia — one of many cities seeking to support the continued growth of cell and gene therapy and connected health industries.
A video from the conference spotlights startup pitches and Q&A with judges in the Life Science track of the Pitch Perfect contest.
A video from the conference spotlights startup pitches with Q&A from judges in the Health IT track of the Pitch Perfect contest.
The 9th Neurodegenerative Drug Development Summit is the industry’s definitive and unrivalled forum focused on revealing hot and promising pockets of innovation in drug discovery for neurodegenerative diseases and combating translational challenges by shining a light on pioneering companies leading the way to meet this dire medical… Read More »9th Annual Neurodegenerative Drug Development Summit
Say Goodbye to the Worry & Uncertainty of Setting Up & Managing an Expanded Access Program This inaugural Operationalize: Expanded Access Programs digital event is here to bring you solutions. Dealing with a diverse and confusing global regulatory landscape, on top of an increasing number of access requests… Read More »Operationalize: Expanded Access Programs Summit
There judges selected two winners — one in the Health IT track, another in the Life Science track.
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target… Read More »5th Microbiome Movement – Drug Development Summit Europe 2021
The final day of the conference, Friday, December 11, includes a panel on precision medicine investment trends, a look at clinical trial design innovation and the life sciences track of our Pitch Perfect startup contest. Register now!
The second day of INVEST Precision Medicine includes presentations by healthcare companies in the Health IT track of the Pitch Perfect startup pitch contest, a panel discussion on interoperability and a panel discussion on building a bioinnovation hub. Register today!
Reimagining Population Health Management: Can Genomics Evolve our Sick Care System into a True Healthcare System [Sponsored]
Learn how health systems, payors, retail, and digital health companies can work together to support population health management. Register for MDisrupt’s webinar here.
Among the areas of interest for companies presenting at Pitch Perfect at INVEST Precision Medicine are clinical stroke detection, making medical research more inclusive, using technology to accelerate the pace of clinical trials, developing more patient friendly drug delivery systems for reconstitutable drugs, and more.
The 4th Antigen Specific Immune Tolerance Digital Summit (ASIT) brings together industry representatives from the fields of autoimmunity, allergy, immuno-oncology and transplantation to tackle the complexities behind autoimmune disorders head on. With momentum building for antigen specific immunotherapies, ASIT 2021 will be the only antigen-specific summit offering thought-leading content to… Read More »4th Antigen Specific Immune Tolerance Summit
The renewed interest in the anti-tumor properties of cytokines has led to an increase in the number of clinical trials that explore the safety and efficacy of cytokine-based drugs, not only as single agents, but also in combination with other immunomodulatory drugs. Therapeutically targeting of… Read More »Cytokine-Based Cancer Immunotherapies Summit
Developing Inhibitors of Specific DDR Targets, in Monotherapy or in Combination, to Treat Predictable & Identifiable DDR-Defective Cancer Indications PARP & DDR therapeutics are exploding thanks to numerous novel next generation synthetic lethal targets reaching an inflection point. The PARP & DDR Inhibitors Summit is… Read More »PARP & DDR Inhibitors Summit 2021
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patients. Hence, the… Read More »Insights+ Key Biosimilars Events of November 2020
A discussion on the different models healthcare stakeholders are developing to cover the cost of costly therapies will be just one of the compelling conversations at the virtual conference from December 9-11. Register today!
Working remotely can have its challenges, why not get together for a fun and rewarding learning experience and refresh your forecasting skills? Following the success of J+D Forecasting’s face to face training, the content has been redesigned to make it suitable for live, online audiences. … Read More »Online Live Team Pharma Forecasting Training Now Available
Despite advances in science and technology, denovo drug development has been a costly and time-consuming process over the past decades. Given these circumstances, drug repositioning and repurposing has appeared as an alternative tool to accelerate drug development processes by seeking new indications for approved/shelved drugs… Read More »AI Driven Repositioning and Repurposing Summit 2021
Here’s a preview of some of the panel discussions at INVEST Precision Medicine, including diagnostics, investment trends, and building a bioinnovation hub.
2020 has been an exciting year for gene therapies targeting blood disorders. Despite FDA’s recent rejection of BioMarin’s hemophilia gene therapy program, the clinical landscape is progressing quickly with Pfizer and Sangamo kicking off their phase 3 and bluebird bio receiving European approval for their… Read More »2nd Gene Therapy for Blood Disorders
The inaugural Gene Therapy Medical Affairs Summit is dedicated to exploring the pivotal internal and external role that Medical Affairs plays in delivering gene therapies to patients. Industry pioneers from leading pharma and biotech companies at various stages of development and commercialization including Novartis Gene Therapy, Orchard Therapeutics & Bluebird Bio will share how… Read More »Gene Therapy Medical Affairs
Are you interested in finding the next breakthrough in immuno-oncology preclinical or clinical development? Recent scientific, clinical breakthroughs and high-profile industry deals have reignited the race to find the next blockbuster TGF-ß inhibitor for immuno-oncology applications. As such, the TGFß for Immuno-Oncology Drug Development Summit (January 26-28) is the… Read More »TGFB for Immuno-Oncology Drug Development Summit
MedCity News is partnering with the New Orleans Business Alliance to host the executive summit November 16-18. It focuses on population health and highlights where innovation and investment are occurring in the field.
Join us at our 2nd Clinical Document World Virtual event on January 19-21, 2021, alongside your TMF, clinical quality, document management, and clinical professionals to explore a strategic clinical process and ensure a complete Document Management Process. This interactive event will include thought-provoking sessions from… Read More »Clinical Document World | Virtual 2021
The healthcare startups targeting chronic conditions and population health presenting at INVEST Pop Health November 16-18 span prescription drug delivery to addressing social isolation.
Accelerate the Bench to Bedside Development of Novel CAR Immunotherapies for Safe, Effective & Affordable Advanced Therapies With CAR-TCR therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this from becoming the ‘sell-out’ therapy that the field had… Read More »Welcome to the CAR-TCR Summit Europe 2021
The summit gathers directors through the C-suite from across life science and healthcare sectors to discuss new developments in precision medicine, investment trends, and how health IT, diagnostics and biopharma technology are being used to improve outcomes.
Frontiers Health has emerged over the last years as one of the premier global events on digital health and innovation in healthcare. In the last five years, the conference has turned into a unique platform for deal making, networking and learning in the industry and… Read More »Join the Frontiers Health 2020 Global Hybrid Conference
With the annual INVEST Population Health virtual conference coming up November 16-18, here’s a look at our collaboration partner New Orleans Business Alliance. It plays a vital role in helping to stimulate the local economy by supporting the development and advancement of the healthcare and… Read More »How is population health innovation unfolding in Louisiana? [Sponsored]
Pharma Middle East Virtual Congress (PPMC2020) layout many new ideas to resolve the most important problems related to the health and wellbeing of humanity. With all the scientific experts and professionals around the world focused on novel trends and advanced strategies emerging in the areas… Read More »Pharma Middle East Virtual Congress (Dec 07 – 08, 2020)
For the second year, MedCity News is partnering with the New Orleans Business Alliance to host an executive summit that focuses on population health and highlights where innovation and investment are occurring in the field.
HLTH aimed to reflect on the success of the decade-old Center for Medicare and Medicaid Innovation (CMMI) by a panel discussion with its directors. Except the first director was never included while his successor tried claiming the mantle of the “inaugural director” riling former colleagues… Read More »A “bald-faced lie” on LinkedIn followed by revisionist history of CMMI at HLTH panel
This Pitch Perfect contest track includes home health startups with technologies spanning respiratory care, virtual nursing, and more.
Patient engagement and experience were coming into focus as part of the overall transformation of healthcare, but the advent of Covid-19 has thrust it to the forefront. Hear from patients, providers, retailers, tech disruptors and others about why patient engagement is paramount.
Startups with tech to improve payer and provider efficiency: Video from MedCity INVEST Digital Health
This Pitch Perfect contest track reflected technology to remove financial barriers for their patients, automating workflows, reducing inefficiency and waste associated with the Prior Authorization process, and more.
Startups focused on chronic conditions and value-based care: Video from MedCity INVEST Digital Health
Finalists in the Pitch Perfect contest track, chronic disease management and value-based care, span virtual care for patients with neurological disorders and family caregivers, digital therapeutics for adolescent mental health, and personalized nutrition coaching to address chronic disease risk.
By having an effective complaint management system, life science organizations have a better chance to ward off inspections by using the appropriate guidelines and regulations. Monitoring complaint trends over time and having a complaint program improves the customer’s experience with your products. Part of the… Read More »Product Complaints & Recalls Virtual Summit
Patient experiences are evolving. How can pharma keep up?By listening to the people who are navigating this new landscape everyday. Integrating personal experiences and patient-reported data, this one-day virtual event features real-time conversations between people living with chronic conditions and Health Union industry experts. Tune in to any… Read More »The COVID-19 Effect: How Pharma Can Adapt to the Evolving Patient Experience
Visit our website: www.rna-editing-summit.com The only industry-led meeting showcasing the recent development of RNA editing mechanisms and dedicated to realizing the research and therapeutics opportunity of RNA editing as quickly as possible. The Primary Industry Platform Solely Dedicated to the Tech Transfer, Translation & Commercialization… Read More »2nd RNA Editing Summit 2020
Visit our website: www.ai-drugdiscovery.com R&D & Clinical Processes for the Future: Accurate, Efficient & Cost-Effective The AI-ML: Drug Discovery and Development Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and… Read More »AI-ML Drug Discovery & Development Summit 2021
Addressing behavioral health challenges for patients and employees: Video from MedCity INVEST Digital Health
In the latest video installment from INVEST Digital Health Virtual, a panel looks at behavioral health from the loneliness epidemic, workplace stress, and other challenges and the innovative tools developed to address these needs.
In the latest video installment from INVEST Digital Health, venture capitalist Michael Yang, Managing Partner, OMERS Ventures, and healthcare entrepreneur Shawn Wagoner, Chief Revenue Officer, Bind Benefits, go head to head to debate the future of health insurance.
We’re making video segments from our INVEST Digital Health conference available for viewing. The first of these installments is a panel discussion on innovation in hospital settings during the public health crisis.
The INVEST Digital Health Virtual conference Pitch Perfect competition, from September 21-25, had some intense competition between the healthcare startup participants. Thanks to all the entrepreneurs, judges and sponsors who took part.
The TIGIT checkpoint has gained much attention in recent years due to the number of roles it plays in several malignancies. TIGIT’s diverse function in multiple cell types has made it a lucrative immunotherapy candidate, with an increasing number of candidates being investigated in pre-clinical and clinical… Read More »TIGIT Therapies Digital Summit
How do we improve behavioral health in meaningful ways? Join the conversation at INVEST Digital Health.
A panel discussion at the conference will examine what is being done to address behavioral health needs from social isolation, accentuated by the public health crisis, to the stress experienced by healthcare professionals.
The upcoming INVEST Digital Health virtual conference September 21-25 will offer a spotlight for this debate to continue. It will also include conversations spanning behavioral health and how hospitals are addressing the pandemic as well as healthcare startup pitches.
The conference, in partnership with healthcare industry association Medical Alley, will include conversations spanning behavioral health, the future of health insurance and how hospitals are addressing the pandemic. It will also spotlight healthcare startups in a pitch contest.
Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, cell therapies pose unique supply chain challenges. From temperature and time sensitivity, to patient-facing delivery and… Read More »Patient-to-Patient Supply for Cell Immunotherapies Summit
Harnessing the Potential of Macrophage Therapies Using Small Molecule, Antibody & Cell Therapy based Approaches for Oncology and Beyond The $4.9 billion acquisition of Forty Seven by Gilead is an example of the explosive excitement and investment into macrophage-directed therapies, utilizing CD47 checkpoint blockades, repolarization… Read More »2nd Macrophage-directed Therapies Summit
Innovation in digital health at hospitals, in the face of Covid-19, and across digital health startups will be the highlights of the conference coming up September 21-25. Register now to get a $100 discount using the code MCN100.
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is coming up quick: Friday, August 21 at 5pm ET! Read more to find out how to apply.
The conference coming up September 21-25 will highlight innovation in digital health at hospitals, in the face of Covid-19, and across digital health startups. Register now to get a $100 discount using the code MCN100.
MedCity News has the most engaged healthcare business audience in the industry. We can collaborate with you to develop customized content or provide a platform for your business to present sponsored thought leadership content highlighting from executives in healthcare and life sciences.
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is August 14 at 5pm ET.
What’s the background on CRFs? A traditional paper case report form is known as a CRF (or paper CRF). An electronic case report form (eCRF) is the same as a CRF, except that it’s electronic. Both abbreviations tend to be used interchangeably, and are also… Read More »Important factors to consider when working with CRFs
With more readers and greater engagement in our content than ever, we have many products that can help you reach your customer base through our content, ads, podcasts and online events. Contact us to learn more.
Patient engagement platform Luma Health was designed to help patients schedule appointment with the doctor without having to wait months. With Covid-19, the startup’s vision has expanded.
We are seeking digital health startups in four categories to take part in our INVEST Digital Health Virtual event in September.
Healthcare startups across health services, health IT, medical devices, biopharma and diagnostics tracks took part in the week-long competition at the conference July 20-24. Here are the winners for the five tracks.
Today marks the last day of INVEST. Check our events page for agenda updates for our other virtual conferences this year including INVEST Digital Health, INVEST Population Health, INVEST Precision Medicine, and our collaboration with HLTH: ENGAGE at HLTH.
Scenario planning and lessons learned from past downturns can help leadership teams guide their startups through an uncertain economy.
Today at MedCity INVEST: Healthcare investment strategies amidst a pandemic and biopharma startups compete
Today’s agenda includes a panel discussion on healthcare investment trends and strategies and the biopharma track of the Pitch Perfect contest, which will include five startups. Register today!
How can companies strike the right balance between growing and scaling their business? A new report shows how an HR team can help.
Medical device startups take center stage today including: Actuated Medical, emocha Health, HT BioImaging, iNNOGING Medical, and Sense Neuro. Register now!
Executives with Kaiser Permanente, Houston Methodist, Providence St. Joseph Health and Highmark Health shared their thoughts on the future of digital health and how they used technology to care for their patients at the start of the Covid-19 pandemic.
How can life science companies benefit from hiring a Professional Employer Organization? [Sponsored]
In an interview, TriNet’s Vice President of Life Sciences, Maria Abouseif, talked about the role Professional Employer Organizations play in helping life science companies navigate the COVID-19 public health crisis.
A panel discussion on digital health in the age of Covid-19 and the health IT track of the Pitch Perfect startup pitching contest are on the agenda for day 2 of the MedCity INVEST conference taking place online July 20-24. Register today!
At MedCity INVEST, Mass General Brigham Chief Information Officer Chris Coburn shared how the health system prepared itself for Covid-19 by scaling up its digital operations.
Our annual INVEST conference, where investors and startups meet, kicks off today as a virtual event. Chris Coburn, chief innovation officer of Mass General Brigham, is a featured speaker and startups in the area of health services will present in the first track of our INVEST… Read More »Here’s what’s on the agenda for Day 1 of MedCity INVEST virtual
Months into the Covid-19 pandemic, the pace of new investments for startups has picked back up. Five VCs shared what’s changed and how they’re working in the midst of the crisis.
Healthcare startups across health IT, diagnostics, biopharma, health services and medical devices will present their technologies to a team of investor judges. Who will rise to the top? Register now to hear these presentations and connect with startups and investors.
A centerpiece of INVEST will be the judges from investment groups who will query participants on their presentations across health IT, diagnostics, health services, medical devices and biopharma.
Here’s your guide to when healthcare startups are pitching at MedCity INVEST. Register now and save.
The INVEST Pitch Perfect contest will be held from July 20-24 and will spotlight healthcare startups across the following tracks: health services, health IT, medical devices, biopharma and diagnostics.
Five health IT startups with technology spanning patient engagement, optimizing care for cancer patients from China, and connected devices will take part in the startup pitching contest INVEST Pitch Perfect July 20-24. Register now while tickets are still available!
Gain insights from the perspectives of healthcare investors from Maverick Ventures, Cultivation Capital, Advocate Aurora Health and Flare Capital on investment trends in 2020 at the online conference July 20-24. Register now and save.
In the medical device track of the online pitch contest, five companies will present their technologies, which span medical imaging to clearing clogs from feeding tubes. Register now!